everolimus

chemical compound
Class type of: LSM-4258 Q421052

Facts

21 properties
Instance of
type of chemical entity
Subclass of
LSM-4258[5]
Active ingredient in
Afinitor, Votubia, Zortress
Canonical SMILES
CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC[3]
Chemical formula
C₅₃H₈₃NO₁₄[4]
Defined daily dose
1.5 mg
Has active ingredient
Everolimus
Has part(s)
carbon[7]
Has parts
carbon
Isomeric SMILES
C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OCCO)C)/C)O)OC)C)C)/C)OC
Legal status (medicine)
boxed warning
LiverTox likelihood score
LiverTox toxicity likelihood category E*
Mass
957.581 Da
Pregnancy category
US pregnancy category D
Significant drug interaction
idelalisib
Stereoisomer of
LSM-5313
Subject has role
protein kinase inhibitors, xenobiotic-transporting ATPase inhibitor, antineoplastic, immunosuppressive drug
World Health Organisation international non-proprietary name
everolimus
🏷️ Also known as
en RAD001 en SDZ-RAD en 40-O-(2-hydroxyethyl)-rapamycin en 42-O-(2-hydroxyethyl)rapamycin en everolimus ar إيفيروليموس de RAD-001 fa اورولیمس fi everolimuusi fr évérolimus hu everolimusz it everolimus ja アフィニトール ja エベロリムス ja サーティカン pl ewerolimus pl RAD-001 pt Afinitor pt everolimo ru эверолимус
🔖 Identifiers · 38
OpenAlex ID
C2779699572
ATC code
L01XE10, L04AA18
CAS Registry Number
159351-69-6
ChEBI ID
68478
ChEMBL ID
CHEMBL1908360
ChemSpider ID
21106307
DSSTOX compound identifier
DTXCID8020599
DSSTox substance ID
DTXSID0040599
DeCS ID
55896
DrugBank ID
DB01590
DrugCentral ID
1118
EC number
621-003-9
Show all 38 identifiers +26
ECHA Substance Infocard ID
100.149.896
Freebase ID
/m/02m34c
Guide to Pharmacology Ligand ID
5889
HSDB ID
8255
Human Metabolome Database ID
HMDB0015529
KEGG ID
D02714
LiverTox ID
Everolimus
MeSH descriptor ID
D000068338
MeSH tree code
D02.540.505.760.500
MedlinePlus drug identifier
a609032
Microsoft Academic ID (discontinued)
2779699572
NDF-RT ID
N0000178379
PatientsLikeMe treatment ID
everolimus
Probes And Drugs ID
PD004083
PubChem CID
6442177
RxNorm CUI
141704
SureChEMBL ID
4378
UK Parliament thesaurus ID
418338
UMLS CUI
C0541315
UniChem compound ID
1077088
WikiProjectMed ID
Everolimus
World Health Organisation international non-proprietary name numeric ID
7863

Report an error or request removal Lineage (PROV-JSON)

🔗 Connections
← Drug or therapy used for treatment 15
Medical condition treated 12
Subject has role 3
Belongs to 1
Has part(s) 1
Has use 1
Legal status (medicine) 1
Physically interacts with 1
Significant drug interaction 1
← Physically interacts with 1
← Significant drug interaction 1
Press Enter · cited answer in seconds

Summary

everolimus is a type of chemical entity[1].

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). everolimus. Retrieved November 18, 2026, from https://4ort.xyz/entity/everolimus
MLA “everolimus.” 4ort.xyz Knowledge Graph, 4ort.xyz, 18 Nov. 2026, https://4ort.xyz/entity/everolimus.
BibTeX @misc{4ortxyz_everolimus_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{everolimus}}, year = {2026}, url = {https://4ort.xyz/entity/everolimus}, note = {Accessed: 2026-11-18}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): everolimus — https://4ort.xyz/entity/everolimus (retrieved 2026-11-18)

Canonical URL: https://4ort.xyz/entity/everolimus · Last refreshed: